Osphena FDA Approval History
FDA Approved: Yes (First approved February 26, 2013)
Brand name: Osphena
Generic name: ospemifene
Dosage form: Tablets
Company: Duchesnay Inc.
Treatment for: Dyspareunia, Atrophic Vaginitis
Osphena (ospemifene) is an estrogen agonist/antagonist indicated for the treatment of symptoms of vulvar and vaginal atrophy due to menopause, including severe dyspareunia and moderate to severe vaginal dryness.
Development timeline for Osphena
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
